ClinicalTrials.Veeva

Menu

Effect of Paracetamol on the Common Cold

GlaxoSmithKline (GSK) logo

GlaxoSmithKline (GSK)

Status and phase

Completed
Phase 2

Conditions

Common Cold

Treatments

Drug: Paracetamol tablets
Drug: Paracetamol hot drink

Study type

Interventional

Funder types

Industry

Identifiers

NCT01277081
C7100991

Details and patient eligibility

About

The aim of this study is to subjectively assess symptoms in subjects suffering from the common cold following a single dose of paracetamol hot drink compared to paracetamol tablet

Enrollment

200 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • Symptoms of the common cold of no more than 120 hours duration
  • Self-rating congestion of at least moderate severity
  • Suffering from at least four symptoms of common cold or flu

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

200 participants in 2 patient groups

Paracetamol hot drink
Active Comparator group
Description:
Hot drink containing paracetamol
Treatment:
Drug: Paracetamol hot drink
Paracetamol tablets
Active Comparator group
Description:
Paracetamol tablets
Treatment:
Drug: Paracetamol tablets

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems